Genzyme quarterly report shows $17.2 million set aside to ensure continued supply of transgenic alpha glucosidase.
[NB- this is an extract from the full press release. the interesting thing to note is the $17.2 Million set aside to ensure continued production of the transgenic enzyme for those patients who need it.]